CDKN2A and neoplasm: Hence, we conducted the first converge comprehensive landscape analysis of FAC-related gene CDKN2A in BRCA, including expression, prognostic values, DNA methylation, tumor microenvironment (TME) analysis, and drug sensitivity of CDKN2A in BRCA.